About argenx US
Reaching Patients Through Immunology Innovation
54 Job openings in Argenx Us
Join us as we transform immunology and deliver medicines that help autoimmune patients get their lives back. argenx is preparing for multidimensional expansion to reach more patients through a rich pipeline of differentiated assets led by VYVGART our firstinclass neonatal Fc receptor More...
Join us as we transform immunology and deliver medicines that help autoimmune patients get their lives back. argenx is preparing for multidimensional expansion to reach more patients through a rich pipeline of differentiated assets led by VYVGART our firstinclass neonatal Fc receptor More...
Join us as we transform immunology and deliver medicines that help autoimmune patients get their lives back. argenx is preparing for multidimensional expansion to reach more patients through a rich pipeline of differentiated assets led by VYVGART our firstinclass neonatal Fc receptor More...
Join us as we transform immunology and deliver medicines that help autoimmune patients get their lives back. argenx is preparing for multidimensional expansion to reach more patients through a rich pipeline of differentiated assets led by VYVGART our firstinclass neonatal Fc receptor More...
Join us as we transform immunology and deliver medicines that help autoimmune patients get their lives back. argenx is preparing for multidimensional expansion to reach more patients through a rich pipeline of differentiated assets led by VYVGART our firstinclass neonatal Fc receptor More...
Join us as we transform immunology and deliver medicines that help autoimmune patients get their lives back. argenx is preparing for multidimensional expansion to reach more patients through a rich pipeline of differentiated assets led by VYVGART our firstinclass neonatal Fc receptor More...
Join us as we transform immunology and deliver medicines that help autoimmune patients get their lives back. argenx is preparing for multidimensional expansion to reach more patients through a rich pipeline of differentiated assets led by VYVGART our firstinclass neonatal Fc receptor More...
Join us as we transform immunology and deliver medicines that help autoimmune patients get their lives back. argenx is preparing for multidimensional expansion to reach more patients through a rich pipeline of differentiated assets led by VYVGART our firstinclass neonatal Fc receptor More...
Join us as we transform immunology and deliver medicines that help autoimmune patients get their lives back. argenx is preparing for multidimensional expansion to reach more patients through a rich pipeline of differentiated assets led by VYVGART our firstinclass neonatal Fc receptor More...
Join us as we transform immunology and deliver medicines that help autoimmune patients get their lives back. argenx is preparing for multidimensional expansion to reach more patients through a rich pipeline of differentiated assets led by VYVGART our firstinclass neonatal Fc receptor More...
Join us as we transform immunology and deliver medicines that help autoimmune patients get their lives back. argenx is preparing for multidimensional expansion to reach more patients through a rich pipeline of differentiated assets led by VYVGART our firstinclass neonatal Fc receptor More...
Join us as we transform immunology and deliver medicines that help autoimmune patients get their lives back. argenx is preparing for multidimensional expansion to reach more patients through a rich pipeline of differentiated assets led by VYVGART our firstinclass neonatal Fc receptor More...
Join us as we transform immunology and deliver medicines that help autoimmune patients get their lives back. argenx is preparing for multidimensional expansion to reach more patients through a rich pipeline of differentiated assets led by VYVGART our firstinclass neonatal Fc receptor More...
Commercial And Medical Affairs Business Information Systems Portfolio Manager
Join us as we transform immunology and deliver medicines that help autoimmune patients get their lives back. argenx is preparing for multidimensional expansion to reach more patients through a rich pipeline of differentiated assets led by VYVGART our firstinclass neonatal Fc receptor More...
